A 4-arm Clinical Trial of Fuse®, EndoCuff™, EndoRings™ and Standard Colonoscopy
Primary Purpose
Colorectal Neoplasms
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Colonoscopy with EndoCuff™
FUSE® Colonoscopy
Colonoscopy with EndoRings™
Standard Colonoscopy
Sponsored by

About this trial
This is an interventional screening trial for Colorectal Neoplasms
Eligibility Criteria
Inclusion Criteria:
- Screening or Surveillance Colonoscopy
Exclusion Criteria:
- Personal history of Colorectal cancer or Inflammatory bowel disease
- Surgical resection of the colon or known colonic stricture
- Personal or family history of Polyposis syndromes or Lynch syndrome
- Referral for incomplete colonoscopy or known therapeutic polyp clearance
- Severe diverticular disease
- Referral for a positive hemoccult test in the past 6 months
- Known coagulopathy
- Inability to provide informed consent
Sites / Locations
- Indiana University Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Arm Label
FUSE® Colonoscopy
Colonoscopy with EndoCuff™
Colonoscopy with EndoRings™
Standard Colonoscopy
Arm Description
A FUSE® system with 3 HD (high-definition) monitors will be used to perform the colonoscopy
An EndoCuff™ distal attachment will be placed at the distal end of a standard colonoscope
An EndoRings™ distal attachment will be placed at the distal end of a standard colonoscope
A standard colonoscope will be used to complete the procedure
Outcomes
Primary Outcome Measures
Adenomas Per Colonoscopy
Secondary Outcome Measures
Number of Participants With Detected Adenoma
Percentage of Participants With Detected Adenoma
Sessile Serrated Polyps Per Colonoscopy
Number of Participants With Detected Sessile Serrated Polyp
Number of patients with 1 or more sessile serrated polyps
Percentage of Participants With Detected Sessile Serrated Polyp
Number of Participants With a Detected Polyp
Percentage of Participants With a Detected Polyp
Cecal Insertion Time
Cecal Insertion Times When no Gastroenterology Fellow Was Involved in Insertion
Inspection Time
Number of Conventional Adenomas by Size in the Right Side of the Colon, Which Includes the Cecum, Ascending Colon, and Hepatic Flexure.
Percent of Conventional Adenomas by Size in the Right Side of the Colon, Which Includes the Cecum, Ascending Colon, and Hepatic Flexure.
Number of Sessile Serrated Polyps by Size in the Right Side of the Colon, Which Includes the Cecum, Ascending Colon, and Hepatic Flexure.
Percent of Sessile Serrated Polyps in the Right Side of the Colon, Which Includes the Cecum, Ascending Colon, and Hepatic Flexure.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02345889
Brief Title
A 4-arm Clinical Trial of Fuse®, EndoCuff™, EndoRings™ and Standard Colonoscopy
Official Title
A 4-arm Randomized Controlled Trial of Fuse®, EndoCuff™, EndoRings™ and Standard Colonoscopy
Study Type
Interventional
2. Study Status
Record Verification Date
February 2019
Overall Recruitment Status
Completed
Study Start Date
February 2015 (Actual)
Primary Completion Date
December 2017 (Actual)
Study Completion Date
December 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Indiana University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Adenoma detection rate (ADR) is a validated marker for reducing the risk of interval colorectal cancer after a screening colonoscopy. Recent studies suggest that novel devices attached to the colonoscope tip may improve the ADR of doctors performing a screening procedure
Detailed Description
Recent studies indicate that continuing medical education, time of colonoscopy during the day, forced longer withdrawal time, use of high definition colonoscopes all result in improving ADR although the gains have only been modest. To this end, adding novel devices to the tip of colonoscope may improve the ability of doctors to perform a better procedure. We therefore propose to identify the increase in ADR with 3 of these devices compared to standard colonoscopy. Fuse colonoscopy (2 cameras embedded at the side of the colonoscope tip providing an increased angle of view), EndoCuff (a plastic cap to fit the tip with flexible arms which hold the mucosa back aiding in inspection), EndoRings (similar to EndoCuff but the arms are wider) have been shown in tandem colonoscopy studies to improve the adenoma miss rates to 7-15% instead of the miss rates seen with standard colonoscopy which is usually about 40%. All these devices are FDA approved and are distributed in the United States.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal Neoplasms
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
1262 (Actual)
8. Arms, Groups, and Interventions
Arm Title
FUSE® Colonoscopy
Arm Type
Active Comparator
Arm Description
A FUSE® system with 3 HD (high-definition) monitors will be used to perform the colonoscopy
Arm Title
Colonoscopy with EndoCuff™
Arm Type
Active Comparator
Arm Description
An EndoCuff™ distal attachment will be placed at the distal end of a standard colonoscope
Arm Title
Colonoscopy with EndoRings™
Arm Type
Active Comparator
Arm Description
An EndoRings™ distal attachment will be placed at the distal end of a standard colonoscope
Arm Title
Standard Colonoscopy
Arm Type
Active Comparator
Arm Description
A standard colonoscope will be used to complete the procedure
Intervention Type
Device
Intervention Name(s)
Colonoscopy with EndoCuff™
Intervention Description
colonoscopy performed with an EndoCuff™ device at the tip of a standard colonoscope
Intervention Type
Device
Intervention Name(s)
FUSE® Colonoscopy
Intervention Description
colonoscopy performed with the FUSE® (full spectrum endoscopy) system
Intervention Type
Device
Intervention Name(s)
Colonoscopy with EndoRings™
Intervention Description
colonoscopy performed with an EndoRings™ device at the tip of a standard colonoscope
Intervention Type
Device
Intervention Name(s)
Standard Colonoscopy
Intervention Description
Current standard of care colonoscopy
Primary Outcome Measure Information:
Title
Adenomas Per Colonoscopy
Time Frame
During Procedure
Secondary Outcome Measure Information:
Title
Number of Participants With Detected Adenoma
Time Frame
During Procedure
Title
Percentage of Participants With Detected Adenoma
Time Frame
During Procedure
Title
Sessile Serrated Polyps Per Colonoscopy
Time Frame
During Procedure
Title
Number of Participants With Detected Sessile Serrated Polyp
Description
Number of patients with 1 or more sessile serrated polyps
Time Frame
During Procedure
Title
Percentage of Participants With Detected Sessile Serrated Polyp
Time Frame
During Procedure
Title
Number of Participants With a Detected Polyp
Time Frame
During Procedure
Title
Percentage of Participants With a Detected Polyp
Time Frame
During Procedure
Title
Cecal Insertion Time
Time Frame
During Procedure
Title
Cecal Insertion Times When no Gastroenterology Fellow Was Involved in Insertion
Time Frame
During Procedure
Title
Inspection Time
Time Frame
During Procedure
Title
Number of Conventional Adenomas by Size in the Right Side of the Colon, Which Includes the Cecum, Ascending Colon, and Hepatic Flexure.
Time Frame
During Procedure
Title
Percent of Conventional Adenomas by Size in the Right Side of the Colon, Which Includes the Cecum, Ascending Colon, and Hepatic Flexure.
Time Frame
During Procedure
Title
Number of Sessile Serrated Polyps by Size in the Right Side of the Colon, Which Includes the Cecum, Ascending Colon, and Hepatic Flexure.
Time Frame
During Procedure
Title
Percent of Sessile Serrated Polyps in the Right Side of the Colon, Which Includes the Cecum, Ascending Colon, and Hepatic Flexure.
Time Frame
During Procedure
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Screening or Surveillance Colonoscopy
Exclusion Criteria:
Personal history of Colorectal cancer or Inflammatory bowel disease
Surgical resection of the colon or known colonic stricture
Personal or family history of Polyposis syndromes or Lynch syndrome
Referral for incomplete colonoscopy or known therapeutic polyp clearance
Severe diverticular disease
Referral for a positive hemoccult test in the past 6 months
Known coagulopathy
Inability to provide informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Douglas Rex, MD
Organizational Affiliation
Indiana University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Indiana University Hospital
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46202
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
29530353
Citation
Rex DK, Repici A, Gross SA, Hassan C, Ponugoti PL, Garcia JR, Broadley HM, Thygesen JC, Sullivan AW, Tippins WW, Main SA, Eckert GJ, Vemulapalli KC. High-definition colonoscopy versus Endocuff versus EndoRings versus full-spectrum endoscopy for adenoma detection at colonoscopy: a multicenter randomized trial. Gastrointest Endosc. 2018 Aug;88(2):335-344.e2. doi: 10.1016/j.gie.2018.02.043. Epub 2018 Mar 9.
Results Reference
derived
Learn more about this trial
A 4-arm Clinical Trial of Fuse®, EndoCuff™, EndoRings™ and Standard Colonoscopy
We'll reach out to this number within 24 hrs